Freedom Broker downgrades Amgen to Hold from Buy, raises price target to $470 from $450
Freedom Broker downgraded Amgen to Hold from Buy and raised its price target to $470 from $450, a 4.4% increase.The price target implies an upside of 2.1% from the Nov 6 close of $460.42.Recent analyst actions on AmgenAcross the five most recent analyst notes published on Amgen over the past 30 day…
Freedom Broker downgraded Amgen to Hold from Buy and raised its price target to $470 from $450, a 4.4% increase.The price target implies an upside of 2.1% from the Nov 6 close of $460.42.Recent analyst actions on AmgenAcross the five most recent analyst notes published on Amgen over the past 30 day…
What's Your Reaction?
